ImmuPharma PLC (LON:IMM)

ImmuPharma PLC (LON:IMM)

Share Price
11.30 p
0.175 (1.57 %)
Market Cap
£15.76 m
Proactive Investors - Run By Investors For Investors

ImmuPharma PLC RNS Release

Result of AGM

RNS Number : 8788S
Immupharma PLC
28 June 2018




                                                                                                                       28 JUNE 2018


This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.






ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed.




For further information please contact:


ImmuPharma PLC (

+ 44 (0) 20 7152 4080

Tim McCarthy, Chairman


Lisa Baderoon, Head of Investor Relations

Twitter: @immupharma


+ 44 (0) 7721 413496





Northland Capital Partners Limited (NOMAD & Joint Broker)

David Hignell, Dugald Carlean, Jamie Spotswood, Corporate Finance

Rob Rees, Corporate Broking



+44 (0)20 3861 6625





Bryan, Garnier & Co. (Joint Broker)

Phil Walker, Corporate Finance

Dominic Wilson, Sales

+44 (0)20 7332 2500










This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

ImmuPharma PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use